Search research articles
Contact Us
Filters
Showing results (1-10 of 10) with videos related to
Page
of 1
Sort By:
World Journal of Methodology
|
July 4, 2015
Current Helicobacter pylori treatment in 2014
Fatih Ermis, Elif Senocak Tasci
Iranian Journal of Kidney Diseases
|
September 5, 2015
Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease
Elif Senocak Tasci, Zerrin Bicik
World Journal of Hepatology
|
August 25, 2015
New treatment strategies for hepatitis C infection
Fatih Ermis, Elif Senocak Tasci
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 29, 2014
Hemodialysis-related headache
Murat Yusuf Sav, Tansu Sav, Elif Senocak, et al.
Sisli Etfal Hastanesi Tip Bulteni
|
January 16, 2025
Turkish Adaptation of QLQ-SH22 Quality of Sexual Life Assessment Scale in Cancer Patients - Validity and Reliability Study
Suveyda Burcak Eris, Ozde Melisa Celayir, Elif Senocak Tasci, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
April 23, 2025
Predicting Osteoporosis in Elderly Cancer Patients Using the Modified Glasgow Prognostic Index
Muge Ustuner, Sabin Goktas Aydin, Ahmet Aydin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 12, 2025
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy
Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel, et al.
Cancers
|
June 27, 2024
Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study
Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, et al.
Scientific Reports
|
July 13, 2025
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study
Maral Martin Mildanoglu, Yasin Kutlu, Onur Bas, et al.
Molecular and Clinical Oncology
|
April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study
Alpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Page
of 1
Search research articles
Search
Showing results (1-10 of 10) with videos related to
Sort By:
Page
of 1
World Journal of Methodology
|
July 4, 2015
Current Helicobacter pylori treatment in 2014
Fatih Ermis, Elif Senocak Tasci
Iranian Journal of Kidney Diseases
|
September 5, 2015
Safe and Successful Treatment With Agalsidase Beta During Pregnancy in Fabry Disease
Elif Senocak Tasci, Zerrin Bicik
World Journal of Hepatology
|
August 25, 2015
New treatment strategies for hepatitis C infection
Fatih Ermis, Elif Senocak Tasci
Hemodialysis International. International Symposium on Home Hemodialysis
|
April 29, 2014
Hemodialysis-related headache
Murat Yusuf Sav, Tansu Sav, Elif Senocak, et al.
Sisli Etfal Hastanesi Tip Bulteni
|
January 16, 2025
Turkish Adaptation of QLQ-SH22 Quality of Sexual Life Assessment Scale in Cancer Patients - Validity and Reliability Study
Suveyda Burcak Eris, Ozde Melisa Celayir, Elif Senocak Tasci, et al.
Cancer Control : Journal of the Moffitt Cancer Center
|
April 23, 2025
Predicting Osteoporosis in Elderly Cancer Patients Using the Modified Glasgow Prognostic Index
Muge Ustuner, Sabin Goktas Aydin, Ahmet Aydin, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
November 12, 2025
A multicenter prospective matched comparative study on osteoporosis risk in cancer patients receiving chemotherapy
Sabin Goktas Aydin, Ahmet Aydin, Burcin Cakan Demirel, et al.
Cancers
|
June 27, 2024
Real-World Efficacy and Safety of First-Line Nivolumab Plus Chemotherapy in Patients with Advanced Gastric, Gastroesophageal Junction, and Esophageal Adenocarcinoma: A Nationwide Observational Turkish Oncology Group (TOG) Study
Yasin Kutlu, Shute Ailia Dae, Feride Yilmaz, et al.
Scientific Reports
|
July 13, 2025
Prognostic and predictive value of systemic inflammatory markers in patients with metastatic gastric and GEJ adenocarcinoma with PD-L1 CPS score ≥ 5: Turkish Oncology Group (TOG) study
Maral Martin Mildanoglu, Yasin Kutlu, Onur Bas, et al.
Molecular and Clinical Oncology
|
April 29, 2025
Real‑world efficacy and safety data of immune checkpoint inhibitors in Turkish patients with metastatic melanoma: A Turkish oncology group retrospective study
Alpaslan Ozgun, Fatma Nihan Akkoc Mustafayev, Izzet Dogan, et al.
Page
of 1